Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)

Saxenda 2023525Novo Nordisk403260 2023121320357101000 1glucagon-like peptide-1, GLP-1 Adobe Stock liraglutideGLP-1 GLP-1LincretinGLP-1LGLP-1GLP-1glucagonGLP-1GLP-1GLP-1GLP-1 receptor agonist GLP-1DPP4dipeptidyl peptidase-4GLP-1GLP-1GLP-1GLP-1GLP-1 GLP-1GLP-1 liraglutideGLP-197%DPP4GLP-113GLP-1Ozempicsemaglutidesemaglutide GLP-1 GLP-1GLP-1liraglutideliraglutideliraglutide GLP-1GLP-1 Adobe Stock GLP-1GLP-1GLP-1short-chain fatty acidsecondary bile acidtryptophan metabolitesLGLP-1 Akkermansia muciniphila AKK2021AKKGLP-1AKK14AKKGLP-1AKKAKKAKKAKKP9P9LGLP-1 GLP-1GLP-1GLP-1P9AKK Clostridium butyricum Bifidobacterium infantis GLP-1 GLP-1 GLP-1GLP-1Eli LillyGLP-1gastric inhibitory polypeptide, GIPtrizepatidetrizepatideGLP-1GLP-1 GLP-1GIP
If a Healthy Connections provider determines that GLP-1 treatment may be appropriate, the provider must prescribe an eligible medication and complete the required prior authorization
Thus, these conserved interactions promote the formation and stability of the bypass motif, which is a key structural determinant for the high potency of Amy analogues at AMYRs 15,16